Metraipolis › archive › dc_4bae1085e3ff

Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe — Europe PMC PMID:34407129

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34407129
DOI
10.1371/journal.pone.0256291
License (as archived)
CC0-1.0
Archived
2026-11-03T06:33:15.616Z
SHA-256 of the archived text
7028052b186f221c5a3551e7e7923d733dedbd7055fd93ad002208bc043d42a4
Stable URL of this page
https://metraipolis.com/documento/dc_4bae1085e3ff

How to cite

Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe — Europe PMC PMID:34407129 — Europe PMC (en), https://europepmc.org/article/MED/34407129 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_4bae1085e3ff (Metraipolis archive dc_4bae1085e3ff, sha256 7028052b186f221c5a3551e7e7923d733dedbd7055fd93ad002208bc043d42a4)
BibTeX
@misc{dc4bae1085e3ff,
  title = {Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe — Europe PMC PMID:34407129},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34407129},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_4bae1085e3ff; sha256 7028052b186f221c5a3551e7e7923d733dedbd7055fd93ad002208bc043d42a4},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34407129. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Zimbabwe has made large strides in addressing HIV. To ensure a continued robust response, a clear understanding of costs associated with its HIV program is critical. We conducted a cross-sectional evaluation in 2017 to estimate the annual average patient cost for accessing Prevention of Mother-To-Child Transmission (PMTCT) services (through antenatal care) and Antiretroviral Treatment (ART) services in Zimbabwe. Twenty sites representing different types of public health facilities in Zimbabwe were included. Data on patient costs were collected through in-person interviews with 414 ART and 424 PMTCT adult patients and through telephone interviews with 38 ART and 47 PMTCT adult patients who had missed their last appointment. The mean and median annual patient costs were examined overall and by service type for all participants and for those who paid any cost. Potential patient costs related to time lost were calculated by multiplying the total time to access services (travel time, waiting time, and clinic visit duration) by potential earnings (US$75 per month assuming 8 hours per day and 5 days per week). Mean annual patient costs for accessing services for the participants was US$20.00 [standard deviation (SD) = US$80.42, median = US$6.00, range = US$0.00-US$12,18.00] for PMTCT and US$18.73 (SD = US$58.54, median = US$8.00, range = US$0.00-US$ 908.00) for ART patients. The mean annual direct medical costs for PMTCT and ART were US$9.78 (SD = US$78.58, median = US$0.00, range = US$0.00-US$ 90) and US$7.49 (SD = US$60.00, median = US$0.00) while mean annual direct non-medical cost for US$10.23 (SD = US$17.35, median = US$4.00) and US$11.23 (SD = US$25.22, median = US$6.00, range = US$0.00-US$ 360.00). The PMTCT and ART costs per visit based on time lost were US$3.53 (US$1.13 to US$8.69) and US$3.43 (US$1.14 to US$8.53), respectively. The mean annual patient costs per person for PMTCT and ART in this evaluation will impact household income since PMTCT and ART services in Zimbabwe are supposed to be free.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-08-18).
Identificativi: PMID 34407129 · PMCID PMC8372940 · DOI 10.1371/journal.pone.0256291.
Descrittori MeSH principali: Cost of Illness.
Pagina: https://europepmc.org/article/MED/34407129 — https://doi.org/10.1371/journal.pone.0256291. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-03T06:25:28.380Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.